Jeffrey L. Mason
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jeffrey L. Mason has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Argiris Efstratiadis
Department of Pathology and The Center for Neurobiology and Behavior, and Department of Genetics and Development, Columbia University, New York, New York 10032
1 shared publicationIoannis Dragatsis
Department of Pathology and The Center for Neurobiology and Behavior, and Department of Genetics and Development, Columbia University, New York, New York 10032
1 shared publicationJ.E. Goldman
1 shared publicationJames E. Goldman
Department of Pathology and The Center for Neurobiology and Behavior, and Department of Genetics and Development, Columbia University, New York, New York 10032
1 shared publicationShouhong Xuan
Department of Pathology and The Center for Neurobiology and Behavior, and Department of Genetics and Development, Columbia University, New York, New York 10032
1 shared publication
Latest Publications
- 20 August 2003
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 23 (20) , 7710-7718
Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination
We examined the role of IGF signaling in the remyelination process by disrupting the gene encoding the type 1 IGF receptor (IGF1R) specifically in the mouse brain by Cre-mediated recombination and then exposing these mutants and normal siblings to cuprizone. This neurotoxicant induces a demyelinating lesion in the corpus callosum that is reversible on termination of the insult. Acute demyelination and oligodendrocyte depletion were the same in mutants and controls, but the mutants did not remyelinate adequately. We observed that oligodendrocyte progenitors did not accumulate, proliferate, or survive within the mutant mice, compared with wild type, indicating that signaling through the IGF1R plays a critical role in remyelination via effects on oligodendrocyte progenitors.
- 20 August 2003
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 23 (20) , 7710-7718
Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination
We examined the role of IGF signaling in the remyelination process by disrupting the gene encoding the type 1 IGF receptor (IGF1R) specifically in the mouse brain by Cre-mediated recombination and then exposing these mutants and normal siblings to cuprizone. This neurotoxicant induces a demyelinating lesion in the corpus callosum that is reversible on termination of the insult. Acute demyelination and oligodendrocyte depletion were the same in mutants and controls, but the mutants did not remyelinate adequately. We observed that oligodendrocyte progenitors did not accumulate, proliferate, or survive within the mutant mice, compared with wild type, indicating that signaling through the IGF1R plays a critical role in remyelination via effects on oligodendrocyte progenitors.
- 1 May 2002
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 20 (1) , 30-42
A2B5+ and O4+ Cycling Progenitors in the Adult Forebrain White Matter Respond Differentially to PDGF-AA, FGF-2, and IGF-1
- 1 May 2002
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 20 (1) , 30-42
A2B5+ and O4+ Cycling Progenitors in the Adult Forebrain White Matter Respond Differentially to PDGF-AA, FGF-2, and IGF-1